Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
This study has been completed.
Study NCT00293072 Information provided by Cambridge University Hospitals NHS Foundation Trust
First Received on February 16, 2006. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
ANCA Associated Vasculitis
Additional conditions recognized in this trial
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Lupus Erythematosus, Systemic
Vasculitis
More general conditions related to this trial
Autoimmune Diseases
Cardiovascular Diseases
Connective Tissue Diseases
Immune System Diseases
Systemic Vasculitis
Vascular Diseases
Interventions listed in this trial
Rituximab
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cambridge University Hospitals NHS Foundation Trust
Roche Pharma AG
Back to top of Main Content
